AGREEMENT |
Chiral ligand agreement set Avantium Technologies and Chiral Quest will team up on R&D into chiral ligand catalysts. In the partnership, Avantium will use Chiral Quest's array of novel chiral ligand catalysts in its own high-throughput experimentation and simulation technology. The goal is development of products for the biopharmaceutical and fine chemicals industries. "Chiral Quest's ligands will add great value to the diversity of our existing catalyst library and greatly benefit the development technology that we provide to our clients," says Alan Lahaise, senior vice president for business development at Avantium. |
Want more information ? Interested in the hidden information ? Click here and do your request. |